SPL starpharma holdings limited

Need for antivirals grows

  1. 1,382 Posts.
    lightbulb Created with Sketch. 308
    Starpharma is certainly in the right growth area as failure to control antibiotic over use continues. The beneficial use of shingles vaccines for viruses in the brain putative cause of Alzheimer’s like Paxlovid and Lagevrio for Covid is only targeted on over 70s and for younger people to obtain private scripts for Shingrix they need to pay $560.
    https://hotcopper.com.au/data/attachments/6940/6940636-747c0c157559eeb84a588121a878b76f.jpg
    Scripp Research Institute https://www.scripps.edu/gallay/sars-cov-2.html are very involved in this research and there are studies not just involving vax but a study in Taiwan 2018 had 90% cut in risk of dementia by taking antivirals for cold sores. So Astodrimer sodium as routine and treatment nasal spray proven for multi viruses could well lead to good Alzheimer’s outcomes - let’s hope Scripps are testing it.

    Fluoride tooth paste has stopped tooth decay
    and
    SPL7013 / VIRALEZE™ could potentially stop brain decay

    We have seen in comparison of antiviral nasal sprays Astodrimer sodium is superior in-vitro and in-vivo
    Last edited by Starlink: 14/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
13.5¢
Change
0.005(3.85%)
Mkt cap ! $56.46M
Open High Low Value Volume
13.5¢ 13.5¢ 13.0¢ $67.38K 517.6K

Buyers (Bids)

No. Vol. Price($)
2 201308 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 195549 6
View Market Depth
Last trade - 16.10pm 08/09/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.